Page last updated: 2024-08-17

adenosine diphosphate and ro 48-3657

adenosine diphosphate has been researched along with ro 48-3657 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goggin, T; Machin, SJ; Mackie, IJ; Timm, U; Wittke, B; Zell, M	1
Modi, NB; Novotny, W; Reimann, JD	1

Trials

2 trial(s) available for adenosine diphosphate and ro 48-3657

Article	Year
Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers. British journal of clinical pharmacology, 1999, Volume: 47, Issue:5 Topics: Adenosine Diphosphate; Administration, Oral; Adult; Amidines; Area Under Curve; Contusions; Dose-Response Relationship, Drug; Double-Blind Method; Heterocyclic Compounds; Humans; Male; Oximes; Peptide Fragments; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Receptors, Thrombin	1999
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin. Journal of clinical pharmacology, 2000, Volume: 40, Issue:5 Topics: Adenosine Diphosphate; Administration, Oral; Adult; Anticoagulants; Area Under Curve; Aspirin; Bleeding Time; Cross-Over Studies; Drug Interactions; Female; Heparin; Humans; Male; Middle Aged; Oximes; Partial Thromboplastin Time; Peptide Fragments; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Prothrombin Time; Receptors, Thrombin	2000

Article

Year

Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers.

British journal of clinical pharmacology, 1999, Volume: 47, Issue:5

Topics: Adenosine Diphosphate; Administration, Oral; Adult; Amidines; Area Under Curve; Contusions; Dose-Response Relationship, Drug; Double-Blind Method; Heterocyclic Compounds; Humans; Male; Oximes; Peptide Fragments; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Receptors, Thrombin

1999

Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered GP IIb/IIIa antagonist, following coadministration of aspirin and heparin.

Journal of clinical pharmacology, 2000, Volume: 40, Issue:5

Topics: Adenosine Diphosphate; Administration, Oral; Adult; Anticoagulants; Area Under Curve; Aspirin; Bleeding Time; Cross-Over Studies; Drug Interactions; Female; Heparin; Humans; Male; Middle Aged; Oximes; Partial Thromboplastin Time; Peptide Fragments; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Prothrombin Time; Receptors, Thrombin

2000